Bert Roland Kari Junno
Gründer bei GABATHER AB
Ursprung des Netzwerks ersten Grades von Bert Roland Kari Junno
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden.
11
| Public Company | Pharmaceuticals: Major | 11 |
| Public Company | Pharmaceuticals: Major | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bert Roland Kari Junno
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AQUA BIO TECHNOLOGY ASA | Chemicals: Major Diversified | Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Chief Executive Officer | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Detroit Mercy | College/University | Graduate Degree | |
| Stockholm School of Economics | College/University | Masters Business Admin | |
| University of Uppsala | College/University | Graduate Degree Doctorate Degree Corporate Officer/Principal | |
| University of Stockholm | College/University | Corporate Officer/Principal Graduate Degree | |
| Université de Bordeaux | College/University | Graduate Degree | |
| University of Lund | College/University | Director/Board Member Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| NAVAMEDIC ASA | Medical Distributors | Director/Board Member | |
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| SERODUS ASA | Biotechnology | Director/Board Member | |
Novartis Sverige AB
 Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Novartis Sverige AB trades pharmaceutical products. It offers products for the treatment of ADHD, multiple sclerosis, urticaria, allergic asthma, psoriasis, chronic obstructive pulmonary disorder, migraine, blood diseases, eye disorder, and other diseases. The company is headquartered in Kista, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Shaanxi University of Traditional Chinese Medicine | College/University | Corporate Officer/Principal | |
| Swedish Pharmaceutical Society | Director/Board Member | ||
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Generic | Chairman Founder | |
Calpro AS
 Calpro AS Miscellaneous Commercial ServicesCommercial Services Calpro AS is a Norwegian bio-tech company that specializes in researching and developing Calprotectin based diagnostic tests. The private company is based in Lysaker, Norway. The company's solutions include a comprehensive range of individual tests and test panels, as well as support for therapeutic drug monitoring. | Miscellaneous Commercial Services | Director/Board Member | |
| Calpro Diagnostics, Inc. | Director/Board Member | ||
| Jotunfjell AS | Director/Board Member | ||
| Magnus Innovasjon AS | Chief Executive Officer | ||
| Ideonfonden AB | Director/Board Member Chief Executive Officer | ||
| Stockholms läns Landsting | General Government | Corporate Officer/Principal | |
| Accequa AB | Founder | ||
| EMOTRA AB (PUBL) | Medical Specialties | Director/Board Member | |
| ARCEDE PHARMA AB | Miscellaneous Commercial Services | Director/Board Member | |
| University of Detroit Mercy School of Law | College/University | Graduate Degree | |
| Portendo Standoff Detection AB | Founder | ||
| Ceratmo AB | Director/Board Member | ||
| CYXONE AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Farma Investment AS
 Farma Investment AS Real Estate Investment TrustsFinance Farma Investment AS invests in shares and real properties. The company was founded on June 23, 2011 and is headquartered in Oslo, Norway. | Real Estate Investment Trusts | Chairman | |
| Biovotec A/S | Director/Board Member | ||
| Ff Bygg Og Vedlikehold AS | Director/Board Member | ||
| Swedish Confederation of Professional Associations | Corporate Officer/Principal | ||
Langseth Advokatfirma DA
 Langseth Advokatfirma DA Miscellaneous Commercial ServicesCommercial Services Langseth Advokatfirma Da is a law firm based in Oslo that offers legal advice and procedure assistance to private individuals and companies. The firm has a team of talented lawyers with extensive experience in dispute resolution, including in court if necessary. One of the main focus areas of the firm is cabin and leisure adjustments, in addition to common legal issues related to real estate. The subject group is led by lawyers with extensive experience in this area. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sinfonia Biotherapeutics AB
 Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a Swedish clinical stage company that develops biologics for neuropathic pain. The private company is based in Huddinge, Sweden. | Biotechnology | Director of Finance/CFO | |
| ECTIN RESEARCH AB | Biotechnology | Director of Finance/CFO | |
| Galecto Biotech AB | Founder | ||
| Accequa GmbH | Director/Board Member | ||
| Nova Law Firm | Corporate Officer/Principal | ||
Advokatfirmaet Nova Da
 Advokatfirmaet Nova Da Miscellaneous Commercial ServicesCommercial Services Advokatfirmaet Nova Da is a medium-sized law firm based in Oslo, Norway with additional offices in Volda and Bodø. The firm has been providing high-quality legal assistance since 1995 and offers a free case evaluation. Nova prides itself on its innovative approach while maintaining a strong foundation of expertise and experience. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Mylifeproducts AS | Chairman | ||
| Aptahem Finans AB | Founder | ||
| Serstech Förvaltning AB | Founder | ||
Melius Pharma AB
 Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| SENSIDOSE AB | Electronic Equipment/Instruments | Director of Finance/CFO Director/Board Member | |
| BIOEXTRAX AB | Biotechnology | Director of Finance/CFO |
Statistik
International
| Schweden | 28 |
| Norwegen | 16 |
| Vereinigte Staaten | 5 |
| Frankreich | 2 |
| China | 2 |
Sektoral
| Health Technology | 15 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Process Industries | 2 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 79 |
| Corporate Officer/Principal | 28 |
| Founder | 24 |
| Chief Executive Officer | 12 |
| Director of Finance/CFO | 12 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Bert Roland Kari Junno
- Unternehmensverbindungen